Published in Phytother Res on January 27, 2015
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol (2006) 1.99
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med (2008) 1.86
New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet (2006) 1.72
Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem Pharmacol (2004) 1.64
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle (2010) 1.60
The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci (2009) 1.57
Plasma homocysteine concentrations in patients with liver cirrhosis. Clin Chem (2002) 1.50
Dilated aortic root is related to a global aortic dilating diathesis. J Vasc Surg (2010) 1.48
The relationship between the antioxidant and the antibacterial properties of galloylated catechins and the structure of phospholipid model membranes. Free Radic Biol Med (2003) 1.44
Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease. J Lab Clin Med (2002) 1.40
Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle (2012) 1.39
[Clinical applications of erythropoietin: Impact on blood transfusion]. Med Clin (Barc) (2002) 1.39
Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation (2004) 1.37
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) (2012) 1.31
Phenolic molecules in virgin olive oils: a survey of their sensory properties, health effects, antioxidant activity and analytical methods. An overview of the last decade. Molecules (2007) 1.25
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle (2013) 1.20
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial. Ann Intern Med (2005) 1.19
Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem (2005) 1.19
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol (2014) 1.18
Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem (2003) 1.16
Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res (2010) 1.15
The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. Sci Rep (2013) 1.14
Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem (2002) 1.13
Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem (2002) 1.11
Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm (2010) 1.09
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. Breast Cancer Res Treat (2007) 1.09
Gerosuppressant metformin: less is more. Aging (Albany NY) (2011) 1.08
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations. Sci Rep (2013) 1.07
Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life (2010) 1.06
The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle (2012) 1.04
Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun (2005) 1.02
The occurrence and bioactivity of polyphenols in Tunisian olive products and by-products: a review. J Food Sci (2012) 1.02
Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study. J Proteome Res (2014) 1.01
Metabolite profiling and quantification of phenolic compounds in methanol extracts of tomato fruit. Phytochemistry (2010) 1.01
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem (2008) 1.01
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine (2009) 1.01
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget (2013) 1.01
Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. Aging (Albany NY) (2011) 1.01
The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke (2007) 1.01
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle (2013) 1.00
Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study. J Lab Clin Med (2005) 0.99
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol (2009) 0.99
Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta (2007) 0.98
Mediterranean diet, olive oil and cancer. Clin Transl Oncol (2006) 0.97
Phenolic-compound-extraction systems for fruit and vegetable samples. Molecules (2010) 0.97
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques. Eur J Clin Invest (2010) 0.96
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis (2006) 0.96
mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). Clin Transl Oncol (2009) 0.96
Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol (2009) 0.96
Phytochemical characterisation for industrial use of pomegranate (Punica granatum L.) cultivars grown in Spain. J Sci Food Agric (2011) 0.95
The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism. AIDS (2005) 0.95
Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr (2014) 0.95
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol (2006) 0.94
Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine (2012) 0.94
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1. Cytokine (2006) 0.94
Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediators Inflamm (2013) 0.93
Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cytotoxic activity against human cancer cells. Food Chem Toxicol (2010) 0.93
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients. J Infect Dis (2010) 0.93
Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205. Cell Cycle (2012) 0.92
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role. J Mol Histol (2010) 0.92
Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment. Oncotarget (2014) 0.91
Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol (2009) 0.91
Determination of the major phenolic compounds in pomegranate juices by HPLC−DAD−ESI-MS. J Agric Food Chem (2013) 0.91
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo. Sci Rep (2013) 0.91
Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine. Pediatr Dermatol (2009) 0.91
The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS (2005) 0.91
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer (2007) 0.91
The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem (2005) 0.90
Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease. Clin Biochem (2007) 0.90
Simultaneous determination of phenolic compounds and saponins in quinoa (Chenopodium quinoa Willd) by a liquid chromatography-diode array detection-electrospray ionization-time-of-flight mass spectrometry methodology. J Agric Food Chem (2011) 0.90
Profiles of phenolic compounds in modern and old common wheat varieties determined by liquid chromatography coupled with time-of-flight mass spectrometry. J Chromatogr A (2011) 0.90
Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim Biophys Acta (2012) 0.90
Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J Agric Food Chem (2010) 0.90
HPLC-ESI-QTOF-MS as a powerful analytical tool for characterising phenolic compounds in olive-leaf extracts. Phytochem Anal (2012) 0.89
tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer (2008) 0.88